Table 2
Predicted changes in age-standardized net survival, by selected cancer type and time period, ages 15 to 99 years at diagnosis, Canada excluding Quebec, 1992-to-1994 to 2012-to-2014 period^{Table 2 Note †}

Table 2
Predicted changes in age-standardized net survival, by selected cancer type and time period, ages 15 to 99 years at diagnosis, Canada excluding Quebec, 1992-to-1994 to 2012-to-2014 period†
Table summary
This table displays the results of Predicted changes in age-standardized net survival. The information is grouped by Cancer (appearing as row headers), Time period, 1992-1994 to 2012-2014, 2002-2004 to 2012-2014, change
(% points), 95% confidence interval
confidence and p-value, calculated using from and to units of measure (appearing as column headers).
Cancer	Time period
	1992-1994 to 2012-2014				2002-2004 to 2012-2014
	change (% points)	95% confidence interval confidence		p-value	change (% points)	95% confidence interval confidence		p-value
	change (% points)	from	to	p-value	change (% points)	from	to	p-value
Tongue	14.4	10.6	18.3	<0.0005	7.9	4.4	11.3	<0.0005
Esophagus	5.0	3.2	6.8	<0.0005	2.4	0.7	4.1	0.007
Stomach	8.7	7.0	10.3	<0.0005	5.2	3.5	6.9	<0.0005
Small intestine	17.4	12.5	22.3	<0.0005	8.7	4.5	12.9	<0.0005
Colon	9.3	8.2	10.4	<0.0005	3.9	2.9	4.9	<0.0005
Rectum	11.4	9.9	12.9	<0.0005	4.2	2.8	5.5	<0.0005
Anus	-0.5	-5.5	4.5	0.848	-0.6	-4.8	3.6	0.785
Liver	10.2	8.1	12.2	<0.0005	3.7	1.7	5.7	<0.0005
Pancreas	3.2	2.3	4.1	<0.0005	2.4	1.5	3.2	<0.0005
Larynx	0.0	-3.6	3.7	0.981	-0.3	-3.9	3.3	0.887
Lung and bronchus	5.4	4.9	6.0	<0.0005	4.5	3.9	5.0	<0.0005
Soft tissue (including heart)	-1.1	-5.3	3.1	0.601	-0.6	-4.1	2.9	0.728
Melanomas of the skin	4.7	2.9	6.5	<0.0005	1.3	-0.1	2.7	0.070
Breast	6.7	6.1	7.4	<0.0005	2.4	1.8	3.0	<0.0005
Cervix uteri	2.4	0.1	4.7	0.040	1.9	-0.4	4.1	0.103
Uterus (body, NOS)	-0.4	-1.8	1.0	0.570	0.2	-1.1	1.4	0.795
Ovary	7.6	5.6	9.6	<0.0005	4.4	2.6	6.3	<0.0005
Prostate	7.2	6.5	7.9	<0.0005	-0.4	-1.0	0.3	0.254
Testis	1.6	0.0	3.2	0.047	0.8	-0.6	2.2	0.258
Bladder (including in situ)^{Table 2 Note ‡}	3.3	1.6	5.0	<0.0005	5.5	4.0	7.0	<0.0005
Kidney and renal pelvis	10.6	8.8	12.4	<0.0005	6.4	4.8	8.0	<0.0005
Brain	2.1	0.6	3.7	0.006	1.0	-0.4	2.4	0.147
Thyroid	4.6	3.3	5.9	<0.0005	1.2	0.4	2.1	0.005
Hodgkin lymphoma	4.8	2.1	7.4	<0.0005	4.4	2.1	6.8	<0.0005
Non-Hodgkin lymphoma	19.6	18.1	21.1	<0.0005	8.4	7.1	9.7	<0.0005
Multiple myeloma	16.8	14.3	19.2	<0.0005	9.6	7.4	11.8	<0.0005
Chronic lymphocytic leukemia	14.0	11.1	16.8	<0.0005	5.6	3.3	8.0	<0.0005
Acute myeloid leukemia	7.6	5.5	9.7	<0.0005	2.7	0.7	4.7	0.008
Chronic myeloid leukemia	23.9	19.3	28.5	<0.0005	3.9	-0.6	8.4	0.880
Mesothelioma	0.2	-3.9	4.2	0.932	2.8	0.3	5.4	0.031
Note † data from Quebec have not been submitted to the Canadian Cancer Registry since the 2010 data year; net survival estimates for 2012 to 2014 predicted using the period method Return to note † referrer Note ‡ the province of Ontario did not submit in situ bladder cancer cases to the Canadian Cancer Registry prior to the 2010 data year Return to note ‡ referrer NOS=not otherwise specified; Sources: Canadian Cancer Registry death linked file (1992-2014); life tables.

Date modified:: 2018-09-19

Language selection

Search and menus

Search

Table 2
Predicted changes in age-standardized net survival, by selected cancer type and time period, ages 15 to 99 years at diagnosis, Canada excluding Quebec, 1992-to-1994 to 2012-to-2014 period^{Table 2 Note †}

Table 2 Predicted changes in age-standardized net survival, by selected cancer type and time period, ages 15 to 99 years at diagnosis, Canada excluding Quebec, 1992-to-1994 to 2012-to-2014 periodTable 2 Note †

Note of appreciation

Standards of service to the public

Copyright

Table 2
Predicted changes in age-standardized net survival, by selected cancer type and time period, ages 15 to 99 years at diagnosis, Canada excluding Quebec, 1992-to-1994 to 2012-to-2014 period^{Table 2 Note †}